Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Marc van de Wetering

Marc van de Wetering

Senior Onderzoeker

Clevers groep

Marc is onderzoeker in de groep van Hans Clevers.

Phone -

Email m.l.vandewetering@prinsesmaximacentrum.nl

Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation
- okt. 2023
- Lin, Lin, et al
- Science
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
- mei 2023
- Irene, Paassen, et al
- Oncogene
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
- aug. 2022
- Michael T, Meister, et al
- EMBO molecular medicine
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
- apr. 2022
- Bram, Herpers, et al
- Nature Cancer
Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network
- dec. 2021
- , et al
- Nature Communications

Bekijk alle publicaties

Marc van de Wetering

Publicaties

Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network